HAL (France)open access
Impact of the vaccination against SARS-CoV-2 campaign on disproportionality indicator from the WHO pharmacovigilance database: A competition bias study from case/non-case analysis
Disproportionality analysis, Adverse drug reaction, Pharmacovigilance, 0, COVID-19 vaccines, Vigibase
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 676855
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.